| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.42B | 2.46B | 2.97B | 3.09B | 2.83B |
| Gross Profit | 1.27B | 1.54B | 2.01B | 1.84B | 1.68B |
| EBITDA | 525.00M | 428.00M | 816.00M | 1.02B | 858.00M |
| Net Income | 21.00M | -75.00M | 270.00M | 490.00M | 396.00M |
Balance Sheet | |||||
| Total Assets | 3.09B | 3.43B | 3.37B | 3.69B | 3.70B |
| Cash, Cash Equivalents and Short-Term Investments | 671.00M | 813.00M | 441.00M | 1.03B | 1.22B |
| Total Debt | 1.52B | 1.92B | 1.57B | 1.49B | 1.40B |
| Total Liabilities | 2.15B | 2.51B | 2.22B | 2.15B | 2.08B |
| Stockholders Equity | 940.00M | 914.00M | 1.15B | 1.53B | 1.61B |
Cash Flow | |||||
| Free Cash Flow | 411.00M | 278.00M | 294.00M | 571.00M | 534.00M |
| Operating Cash Flow | 484.00M | 429.00M | 506.00M | 750.00M | 699.00M |
| Investing Cash Flow | -114.00M | -127.00M | -231.00M | -153.00M | -167.00M |
| Financing Cash Flow | -459.00M | 48.00M | -865.00M | -815.00M | -578.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £1.59B | 5.13 | 12.32% | ― | 9.64% | 71.55% | |
73 Outperform | £3.06B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £7.06B | 298.74 | 0.69% | 1.18% | 14.13% | -96.12% | |
59 Neutral | £648.99M | -23.98 | 4.40% | 3.36% | -2.88% | 431.91% | |
53 Neutral | £4.05B | 185.63 | 2.29% | ― | -1.67% | ― | |
52 Neutral | £78.23M | -2.45 | 370.62% | ― | -15.13% | 48.56% |